Merz, Inc. Announces Promotion of Katrina Church to Vice President, Chief Compliance Officer
GREENSBORO, N.C., July 9, 2012 /PRNewswire/ -- Merz, Inc. (US affiliate of Merz Pharma Group) today announced that Katrina Church has been promoted to vice president, chief compliance officer, effective July 1, 2012. Church will be responsible for providing strategic and operational leadership relating to compliance issues.
"Katrina brings extensive experience and a wealth of legal knowledge in pharmaceutical regulatory compliance to her new role," said Bill Humphries, president and chief executive officer of Merz, Inc. "Merz, Inc. is committed to a tight set of core values that foster a positive, productive and unified work environment. As a company, we do what is right even when it is not easy. Katrina plays a vital role in ensuring that we uphold the highest standards and values in this dynamic regulatory environment. We look forward to working with her on the many compliance requirements facing pharmaceutical companies today."
Church joined Merz in November 2009 and has more than 20 years of legal experience in various areas, including private legal practice and in-house corporate counsel positions. Prior to joining Merz, she was employed by Connetics, Inc. where she served as general counsel. Following the acquisition of Connetics by Stiefel Laboratories, Inc., in 2006, she provided legal consulting services to Stiefel.
Church graduated Magna Cum Laude from Duke University and obtained her Juris Doctor from the New York University School of Law. She is admitted to the Bar in California, certified in Healthcare Compliance and is a member of the American Corporate Counsel Association, American Health Lawyers Association, Health Care Compliance Association, and the Society of Corporate Compliance and Ethics. Church will remain at Merz, Inc. headquarters in Greensboro, N.C.
About Merz, Inc.
Merz, Inc. develops and commercializes products for Merz Pharma Group. Areas of therapeutic focus include Neurology, Physiatry, Dermatology, Aesthetics, and Podiatry.
About Merz Pharma Group
Globally, the companies of Merz Pharma Group are focused on medications for treating neurological and psychiatric illnesses and thereby assume a leading role in the field of Alzheimer research. Another important area of competency of Merz is Clinical Dermatology and Aesthetic Medicine. Merz is also active in the Health sector outside of the pharmacy. In the field of consumer products, with its established brands of tetesept® and Merz Spezial®, Merz Consumer Care is a leading provider of products for self-medication, nutritional supplements and skin care in the German-speaking area. Merz Pharma Group is a privately owned company, founded in 1908 in Frankfurt, Germany.
SOURCE Merz, Inc.
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article